Description

In the show we’ll dive into:

• How AI adds to reading and interpreting genomic information from blood or biopsy
• Pros & cons of “black box” vs “explainable white box” AI algorithms
• Where the opportunities are to diagnose and manage disease better
• What is holding us back from curing inflammatory & autoimmune diseases today?

And we'll answer your questions

Amrie Grammer, PhD is the Co-Founder and President of Ampel BioSolutions, a precision medicine company that uses RNA analytics and predictive AI to manage disease. Follow her at: https://www.linkedin.com/in/amrie-grammer-phd-1351551b/

Steven Wardell is the Managing Partner of Wardell Advisors, a consulting firm focused on growth, fundraising, and strategic alternatives for digital health companies. He is the host of DigitalHealth InvestorTalk and the author of The Future of Digital Health. Follow for digital health insights at X.com/StevenWardell.

Follow on Eventbrite to hear about new events and live shows: StevenWardell.EventBrite.com.

Subscribe to the podcast!

Apple Podcasts (new show link): https://podcasts.apple.com/us/podcast/digitalhealth-investortalk-show/id1739850633

Spotify (new show link): https://open.spotify.com/show/42dV5Wnag97l2rtIDpxmlJ